报价延迟最少15分钟:2025/11/07 13:27 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
40.2728 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.53/0.65
|
|
企业价值
9.46B
|
| 资产负债 |
|
每股账面净值
2.55
|
| 现金流量 |
|
现金流量率
0.03
|
| 损益表 |
|
收益
1.48B
|
|
每股收益
3.48
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/11/07 13:27 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers. |
